Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer
Fan Yang, Shi-Xu Lv, Lin Lv, Ye-Huan Liu, Si-Yang Dong, Zhi-Han Yao, Xuan-xuan Dai, Xiao-Hua Zhang, Ou-Chen Wang Department of Surgical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China Background: Luminal subtyp...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-11-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/identification-of--lncrna-fam83h-as1-as-a-novel-prognostic-marker-in-l-peer-reviewed-article-OTT |
id |
doaj-b77d639d70124bd0adf1df3c83970706 |
---|---|
record_format |
Article |
spelling |
doaj-b77d639d70124bd0adf1df3c839707062020-11-25T00:25:11ZengDove Medical PressOncoTargets and Therapy1178-69302016-11-01Volume 97039704530056Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancerYang FLv SLv LLiu YDong SYao ZDai XZhang XWang OFan Yang, Shi-Xu Lv, Lin Lv, Ye-Huan Liu, Si-Yang Dong, Zhi-Han Yao, Xuan-xuan Dai, Xiao-Hua Zhang, Ou-Chen Wang Department of Surgical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China Background: Luminal subtype breast cancer accounts for a predominant number of breast cancers. Considering the heterogeneity of the disease, it is urgent to develop novel biomarkers to improve risk stratification and optimize therapy choices. Long non-coding RNA (lncRNA) represents an emerging and understudied class of transcripts that play a significant role in cancer biology. Growing knowledge of cancer-associated lncRNAs contributes to the development of molecular markers for prognosis evaluation and gene therapy.Materials and methods: Three pairs of primary luminal subtype breast cancer tissues and adjacent non-cancerous tissues were collected and sequenced. EBseq algorithm was used to identify differentially expressed lncRNAs. RNA sequencing data from The Cancer Genome Atlas (TCGA) database were used to validate the robustness of our RNA-seq results. Kaplan–Meier and Cox regression analyses were utilized to assess the association between the lncRNAs and overall survival of patients in TCGA cohort.Results: A total of 796 lncRNAs were significantly dysregulated in luminal subtype breast cancer, including 436 upregulated and 360 downregulated lncRNAs. Among them, FAM83H antisense RNA 1 (FAM83H-AS1) was the most upregulated lncRNA, whereas GSN antisense RNA 1 (GSN-AS1) was the most downregulated lncRNA. Moreover, we proved that the high expression level of FAM83H-AS1 indicated unfavorable prognosis not only in luminal subtype breast cancer but also in all subtype breast cancers. To the best of our knowledge, this is the first report indicating that FAM83H-AS1 was involved in luminal subtype breast cancer and was an independent prognostic indicator.Conclusion: Our study provides a rich resource to the research community for further identifying lncRNAs with diagnostic and therapeutic potentials and exploring biological function of lncRNAs in luminal subtype breast cancer. Keywords: breast cancer, long non-coding RNA, FAM83H-AS1, prognosishttps://www.dovepress.com/identification-of--lncrna-fam83h-as1-as-a-novel-prognostic-marker-in-l-peer-reviewed-article-OTTbreast cancerlong non-coding RNAFAM83H-AS1prognosis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yang F Lv S Lv L Liu Y Dong S Yao Z Dai X Zhang X Wang O |
spellingShingle |
Yang F Lv S Lv L Liu Y Dong S Yao Z Dai X Zhang X Wang O Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer OncoTargets and Therapy breast cancer long non-coding RNA FAM83H-AS1 prognosis |
author_facet |
Yang F Lv S Lv L Liu Y Dong S Yao Z Dai X Zhang X Wang O |
author_sort |
Yang F |
title |
Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer |
title_short |
Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer |
title_full |
Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer |
title_fullStr |
Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer |
title_full_unstemmed |
Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer |
title_sort |
identification of lncrna fam83h-as1 as a novel prognostic marker in luminal subtype breast cancer |
publisher |
Dove Medical Press |
series |
OncoTargets and Therapy |
issn |
1178-6930 |
publishDate |
2016-11-01 |
description |
Fan Yang, Shi-Xu Lv, Lin Lv, Ye-Huan Liu, Si-Yang Dong, Zhi-Han Yao, Xuan-xuan Dai, Xiao-Hua Zhang, Ou-Chen Wang Department of Surgical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China Background: Luminal subtype breast cancer accounts for a predominant number of breast cancers. Considering the heterogeneity of the disease, it is urgent to develop novel biomarkers to improve risk stratification and optimize therapy choices. Long non-coding RNA (lncRNA) represents an emerging and understudied class of transcripts that play a significant role in cancer biology. Growing knowledge of cancer-associated lncRNAs contributes to the development of molecular markers for prognosis evaluation and gene therapy.Materials and methods: Three pairs of primary luminal subtype breast cancer tissues and adjacent non-cancerous tissues were collected and sequenced. EBseq algorithm was used to identify differentially expressed lncRNAs. RNA sequencing data from The Cancer Genome Atlas (TCGA) database were used to validate the robustness of our RNA-seq results. Kaplan–Meier and Cox regression analyses were utilized to assess the association between the lncRNAs and overall survival of patients in TCGA cohort.Results: A total of 796 lncRNAs were significantly dysregulated in luminal subtype breast cancer, including 436 upregulated and 360 downregulated lncRNAs. Among them, FAM83H antisense RNA 1 (FAM83H-AS1) was the most upregulated lncRNA, whereas GSN antisense RNA 1 (GSN-AS1) was the most downregulated lncRNA. Moreover, we proved that the high expression level of FAM83H-AS1 indicated unfavorable prognosis not only in luminal subtype breast cancer but also in all subtype breast cancers. To the best of our knowledge, this is the first report indicating that FAM83H-AS1 was involved in luminal subtype breast cancer and was an independent prognostic indicator.Conclusion: Our study provides a rich resource to the research community for further identifying lncRNAs with diagnostic and therapeutic potentials and exploring biological function of lncRNAs in luminal subtype breast cancer. Keywords: breast cancer, long non-coding RNA, FAM83H-AS1, prognosis |
topic |
breast cancer long non-coding RNA FAM83H-AS1 prognosis |
url |
https://www.dovepress.com/identification-of--lncrna-fam83h-as1-as-a-novel-prognostic-marker-in-l-peer-reviewed-article-OTT |
work_keys_str_mv |
AT yangf identificationoflncrnafam83has1asanovelprognosticmarkerinluminalsubtypebreastcancer AT lvs identificationoflncrnafam83has1asanovelprognosticmarkerinluminalsubtypebreastcancer AT lvl identificationoflncrnafam83has1asanovelprognosticmarkerinluminalsubtypebreastcancer AT liuy identificationoflncrnafam83has1asanovelprognosticmarkerinluminalsubtypebreastcancer AT dongs identificationoflncrnafam83has1asanovelprognosticmarkerinluminalsubtypebreastcancer AT yaoz identificationoflncrnafam83has1asanovelprognosticmarkerinluminalsubtypebreastcancer AT daix identificationoflncrnafam83has1asanovelprognosticmarkerinluminalsubtypebreastcancer AT zhangx identificationoflncrnafam83has1asanovelprognosticmarkerinluminalsubtypebreastcancer AT wango identificationoflncrnafam83has1asanovelprognosticmarkerinluminalsubtypebreastcancer |
_version_ |
1725349602954051584 |